2025 Annual Meeting | H43 - Coffee Connect—Women Researchers (Research Hub)
Program Materials Program Evaluations
08:00 AM - 08:45 AM PDT | Discussion |
Coffee Connect—Women Researchers
Neha Dangayach, MD, FAAN, Shibani S. Mukerji, MD, PhD, Alissa A. Thomas, MD, FAAN |
Neha Dangayach, MD, FAAN | Dr. Dangayach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jacob's Institute. Dr. Dangayach has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dangayach has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association: SVIN journal. The institution of Dr. Dangayach has received research support from The Aneurysm and AVM Foundation. The institution of Dr. Dangayach has received research support from Neurosteer. Dr. Dangayach has received research support from Visionable. The institution of Dr. Dangayach has received research support from CeibaHealth. The institution of Dr. Dangayach has received research support from Cullman Family Foundation. Dr. Dangayach has received publishing royalties from a publication relating to health care. Dr. Dangayach has received publishing royalties from a publication relating to health care. |
Shibani S. Mukerji, MD, PhD | Dr. Mukerji has stock in Gilead Science. Dr. Mukerji has stock in Ranpack. Dr. Mukerji has stock in Snowflake. An immediate family member of Dr. Mukerji has stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital. |
Alissa A. Thomas, MD, FAAN | The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals. |